ArticleScience advances2026

Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

Felicia Zhang Perkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.